#158349

JU77R cell line

Cat. #158349

JU77R cell line

Cat. #: 158349

Sub-type: Continuous

Unit size: 1x10^6 cells / vial

Availability: 10-12 weeks

Organism: Human

Tissue: Lung

Disease: Cancer

Model: Cancer Model

£575.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Sarah A Martin

Institute: Queen Mary University of London

Tool Details
Target Details
Handling
References

Tool Details

*FOR RESEARCH USE ONLY

  • Name: JU77R cell line
  • Tool sub type: Continuous
  • Parental cell: JU77
  • Organism: Human
  • Tissue: Lung
  • Disease: Cancer
  • Growth properties: Human mesothelioma cell line resistant to pegylated arginine deiminase (ADI-PEG20).
  • Model: Cancer Model
  • Production details: JU77 cells were incubated with 10ug/ml ADI-PEG20 in RPMI-1640 media supplemented with 2% FBS and re-treated every week. After approximately 2 months, colonies were picked and seeded in a 96-well plate with 10ug/ml ADI-PEG20. A surviving clone (JU777R) was gradually expanded and maintained in 1ug/ml ADI-PEG20.
  • Cellosaurus id: TBC

Target Details

  • Target: Human mesothelioma cell line resistant to pegylated arginine deiminase (ADI-PEG20)

Handling

  • Format: Frozen
  • Growth medium: RPMI-1640 media (Sigma-Aldrich) supplemented with 10% fetal bovine serum (FBS; Invitrogen), 100 U/ml penicillin, and 100ug/ml streptomycin at 37?‚°C/5% CO2.
  • Unit size: 1x10^6 cells / vial
  • Shipping conditions: Dry ice

References

  • Locke et al. 2016. Cell Rep. 16(6):1604-1613. PMID: 27452468.